Sort
8,912 grants matching “sars cov 2”
NIAID DCR OPERATIONAL TASK ORDERCOVID FUNDING SUPPORTS THE NIAID DCR COVID WEBSITE AND THE VARIANT TESTING SAVE PROGRAM FOR VARIANT TESTING.
$1,200,000Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI
Structural Characterization of SARS-CoV-2 Genome Organization by NMR
$1,200,000Tatyana Polenova · University Of Delaware · · FY2023 · BIO
CIVICS PROGRAM - SARS-CoV-2 STUDIES
$1,198,308Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
$1,197,841Michael S. Diamond · Washington University · R01 · FY2023 · AI
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,197,554Alice S. Ryan · University Of Maryland Baltimore · P30 · FY2025 · AG
Cancer Center Support Grant Supplement: Clinical Evaluation of a Q GRFT Nasal Spray for Prevention of SARS-CoV-2
$1,197,257Robert L Ferris · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Immunologic Monitoring and Cellular Products Laboratory
$1,197,257Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P30 · FY2020 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,197,237Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,196,757Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2023 · AG
Clinical and Informatics Research on Large Clinical Databases
$1,196,486Clement McDonald · National Library Of Medicine · ZIA · FY2025 · LM
NSF/MCB-BSF: Sentinels: Viral First Responder Cells (VFRCs) for COVID-19 and Future Rapidly Emerging Infectious Diseases
$1,195,831Ron Weiss · Massachusetts Institute Of Technology · · FY2021 · BIO
2/2 REPRIEVE Extension for Trial Completion
$1,195,255Michael Tse-Yin Lu · Massachusetts General Hospital · U24 · FY2024 · HL
Localized mHealth approach to boosting COVID-19 testing and vaccine literacy, access, and uptake among women with criminal legal system involvement
$1,195,191Jason Edwin Glenn · University Of Kansas Medical Center · U01 · FY2023 · MD
SBIR Phase II: Development of an End-to-End Solution for High-Volume Water Microbiological Testing
$1,194,719Abdennour Abbas · Frontline Biotechnologies Inc. · · FY2024 · TIP
Sequence analysis of SARS-CoV-2 for rapid identification of novel variants
$1,194,074National Institute Of Allergy And Infectious Diseases · Y01 · FY2022 · AI
Human antibody-based countermeasures against the Wuhan Coronavirus SARS-CoV-2
$1,193,360Michael S. Diamond · Washington University · R01 · FY2024 · AI
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
$1,193,309Michael S. Diamond · Washington University · R01 · FY2020 · AI
University of Maryland Claude D. Pepper Older Americans Independence Center (OAIC)
$1,190,048Jay Steven Magaziner · University Of Maryland Baltimore · P30 · FY2022 · AG
Using the multiphase optimization strategy (MOST) to optimize an intervention to increase COVID-19 testing for Black and Latino/Hispanic frontline essential workers
$1,188,003Marya Gwadz · New York University · U01 · FY2023 · MD
Molecular Correlates of Symptom Severity in ME/CFS
$1,186,570W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2024 · NS
Core D: Clinical Research
$1,186,474Ighovwerha Ofotokun · Emory University · P30 · FY2022 · AI
Imaging neuroglial mechanisms of neuropathic pain-opioid interaction in HIV
$1,186,451Marco Luciano Loggia · Massachusetts General Hospital · R01 · FY2022 · DA
Interactions of SARS-CoV-2 N-protein
$1,186,129Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2023 · EB
SASEA
$1,184,630Rebecca Kathleen Fielding-Miller · University Of California, San Diego · U01 · FY2023 · HD
Targeting CD180 to induce anti-KSHV response in nonhuman primates
$1,184,569Scott W Wong · Oregon Health & Science University · U01 · FY2025 · CA